Red blood cells, or erythrocytes, play important innate immune functions, including the capture and delivery of bacterial pathogens to the antigen presenting cells (APCs) in the spleen.
The researchers harnessed erythrocyte immune functions to develop Erythrocyte Driven Immune Targeting (EDIT), a method to deliver vaccine nanoparticles from the surface of red blood cells to the APCs in the spleen and generate cellular and humoral immune responses.
At an incubation ratio of 300:1 (nanoparticles: erythrocytes), nanoparticle loading per erythrocyte was found to be optimal for developing enough shear resistance to ensure that the nanoparticles were mostly delivered to the spleen rather than the lungs.
Once the nanoparticles reached the spleen, alterations to the erythrocyte membrane led to their prompt capture by spleen APCs, without the capture of the carrier cell. EDIT led to improved humoral and cellular immune responses, with the erythrocyte-delivered nanoparticles resulting in higher antibody response, higher central memory T cell response, and lower regulatory T cells, compared with free nanoparticles.
In a mouse model of prophylaxis, EDIT-mediated immune responses were found to significantly slow tumor growth and increase the window for therapeutic interventions.
According to the authors, EDIT could be used for erythrocyte-mediated delivery of antigens to stimulate enhanced systemic immunity and serve as the basis for vaccination strategies.
https://www.pnas.org/content/early/2020/07/13/2002880117
Using red blood cells to deliver vaccine to spleen
- 1,302 views
- Added
Edited
Latest News
Complete vascularization of…
By newseditor
Posted 28 Mar
Immune cells identified as…
By newseditor
Posted 28 Mar
TB blood test which could d…
By newseditor
Posted 27 Mar
Propionate supplementation…
By newseditor
Posted 27 Mar
Role of human Kallistatin i…
By newseditor
Posted 26 Mar
Other Top Stories
Long-non coding RNAs promote breast cancer metastasis
Read more
How shattered chromosomes (chromothripsis) make cancer cells drug-r…
Read more
Phase 3 clinical trial reveals life saving drug for acute myeloid l…
Read more
Brain cancer linked to tissue healing
Read more
The hexosamine biosynthesis pathway is a targetable liability in KR…
Read more
Protocols
Spatial proteomics in neuro…
By newseditor
Posted 28 Mar
All-optical presynaptic pla…
By newseditor
Posted 23 Mar
Epigenomic tomography for p…
By newseditor
Posted 20 Mar
A mouse DRG genetic toolkit…
By newseditor
Posted 17 Mar
An optogenetic method for t…
By newseditor
Posted 13 Mar
Publications
A microfluidic platform int…
By newseditor
Posted 28 Mar
Salmonella manipulates macr…
By newseditor
Posted 28 Mar
BHLHE40/41 regulate microgl…
By newseditor
Posted 28 Mar
Balancing neuronal activity…
By newseditor
Posted 28 Mar
OSBP-mediated PI(4)P-choles…
By newseditor
Posted 28 Mar
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar